ABEO - Abeona Therapeutics Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
2,998
837
889
Operating Expenses
Research Development
48,566
48,566
38,698
16,989
10,655
Selling General and Administrative
20,705
20,705
20,106
10,943
13,290
Total Operating Expenses
77,090
77,090
61,164
28,673
24,770
Operating Income or Loss
-77,090
-77,090
-58,166
-27,836
-23,881
Interest Expense
400
400
11
8
6
Income Before Tax
-76,282
-76,282
-56,671
-27,319
-21,873
Income from Continuing Operations
-76,282
-76,282
-56,671
-27,319
-21,873
Net Income
-76,282
-76,282
-56,671
-27,319
-21,873
Net Income available to common shareholders
-76,282
-76,282
-56,671
-27,319
-21,873
Basic EPS
-
-
-1.19
-0.66
-0.64
Diluted EPS
-
-
-1.19
-0.66
-0.64
Basic Average Shares
-
-
47,528
41,637
34,180
Diluted Average Shares
-
-
47,528
41,637
34,180
EBITDA
-
-68,063
-54,300
-26,570
-21,042